bioMérieux S.A. (LON:0RUG)

bioMérieux Statistics

Total Valuation

bioMérieux has a market cap or net worth of GBP 9.54 billion. The enterprise value is 9.66 billion.

Market Cap	9.54B
Enterprise Value	9.66B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	Jun 9, 2025

Share Statistics

Current Share Class	118.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	18.08%
Float	44.73M

Valuation Ratios

The trailing PE ratio is 29.46 and the forward PE ratio is 19.25.

PE Ratio	29.46
Forward PE	19.25
PS Ratio	2.70
PB Ratio	2.83
P/TBV Ratio	3.98
P/FCF Ratio	25.34
P/OCF Ratio	14.13
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.75, with an EV/FCF ratio of 25.64.

EV / Earnings	29.81
EV / Sales	2.69
EV / EBITDA	10.75
EV / EBIT	15.78
EV / FCF	25.64

Financial Position

The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.13.

Current Ratio	2.27
Quick Ratio	1.30
Debt / Equity	0.13
Debt / EBITDA	0.49
Debt / FCF	1.15
Interest Coverage	45.70

Financial Efficiency

Return on equity (ROE) is 9.49% and return on invested capital (ROIC) is 12.61%.

Return on Equity (ROE)	9.49%
Return on Assets (ROA)	8.23%
Return on Invested Capital (ROIC)	12.61%
Return on Capital Employed (ROCE)	16.14%
Weighted Average Cost of Capital (WACC)	7.65%
Revenue Per Employee	244,494
Profits Per Employee	22,416
Employee Count	14,754
Asset Turnover	0.77
Inventory Turnover	1.81

Taxes

In the past 12 months, bioMérieux has paid 118.64 million in taxes.

Income Tax	118.64M
Effective Tax Rate	27.18%

Stock Price Statistics

The stock price has decreased by -19.02% in the last 52 weeks. The beta is 0.66, so bioMérieux's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-19.02%
50-Day Moving Average	104.92
200-Day Moving Average	113.87
Relative Strength Index (RSI)	18.70
Average Volume (20 Days)	95,115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, bioMérieux had revenue of GBP 3.53 billion and earned 323.93 million in profits. Earnings per share was 2.72.

Revenue	3.53B
Gross Profit	1.99B
Operating Income	603.29M
Pretax Income	436.48M
Net Income	323.93M
EBITDA	856.76M
EBIT	603.29M
Earnings Per Share (EPS)	2.72

Balance Sheet

The company has 326.16 million in cash and 434.08 million in debt, with a net cash position of -107.92 million.

Cash & Cash Equivalents	326.16M
Total Debt	434.08M
Net Cash	-107.92M
Net Cash Per Share	n/a
Equity (Book Value)	3.38B
Book Value Per Share	28.56
Working Capital	1.09B

Cash Flow

In the last 12 months, operating cash flow was 675.21 million and capital expenditures -298.56 million, giving a free cash flow of 376.65 million.

Operating Cash Flow	675.21M
Capital Expenditures	-298.56M
Free Cash Flow	376.65M
FCF Per Share	n/a

Margins

Gross margin is 56.27%, with operating and profit margins of 17.08% and 9.17%.

Gross Margin	56.27%
Operating Margin	17.08%
Pretax Margin	12.35%
Profit Margin	9.17%
EBITDA Margin	24.25%
EBIT Margin	17.08%
FCF Margin	10.66%

Dividends & Yields

This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 0.81%.

Dividend Per Share	0.76
Dividend Yield	0.81%
Dividend Growth (YoY)	4.97%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.08%
Shareholder Yield	0.73%
Earnings Yield	3.39%
FCF Yield	3.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 20, 2017. It was a forward split with a ratio of 3.

Last Split Date	Sep 20, 2017
Split Type	Forward
Split Ratio	3

Scores

bioMérieux has an Altman Z-Score of 6.89 and a Piotroski F-Score of 7.

Altman Z-Score	6.89
Piotroski F-Score	7